IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 28, Issue 14, Pages 2348-2355
Publisher
American Society of Clinical Oncology (ASCO)
Online
2010-04-06
DOI
10.1200/jco.2009.27.3730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias
- (2009) Guido Marcucci et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia
- (2009) R. Tang et al. BLOOD
- Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
- (2009) S. Schnittger et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- MicroRNA-1 and MicroRNA-133 in Spontaneous Myocardial Differentiation of Mouse Embryonic Stem Cells
- (2009) Tomohide Takaya et al. CIRCULATION JOURNAL
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors
- (2009) Fonnet E. Bleeker et al. HUMAN MUTATION
- Detection and characterization of soluble CD93 released during inflammation
- (2009) Mallary C. Greenlee et al. INFLAMMATION RESEARCH
- Prognostic Importance ofMN1Transcript Levels, and Biologic Insights FromMN1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2009) Christian Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- ERGExpression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis ofERG, MN1, andBAALCTranscript Levels Using Oligonucleotide Microarrays
- (2009) Klaus H. Metzeler et al. JOURNAL OF CLINICAL ONCOLOGY
- Favorable Prognostic Impact ofNPM1Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
- (2009) Heiko Becker et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Metabolic Enzymes as Oncogenes or Tumor Suppressors
- (2009) Craig B. Thompson NEW ENGLAND JOURNAL OF MEDICINE
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
- (2008) C. Langer et al. BLOOD
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- (2008) Z. Zeng et al. BLOOD
- Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party
- (2008) Priya Virappane et al. JOURNAL OF CLINICAL ONCOLOGY
- Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2008) Peter Paschka et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With,CEBPAMutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
- (2008) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720
- (2008) Maria R. Baer et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
- (2008) Marina Bousquet et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Disorders caused by deficiency of succinate-CoA ligase
- (2008) E. Ostergaard JOURNAL OF INHERITED METABOLIC DISEASE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal Cytogenetics
- (2008) Verena Gaidzik et al. SEMINARS IN ONCOLOGY
- Deregulation of Signaling Pathways in Acute Myeloid Leukemia
- (2008) Claudia Scholl et al. SEMINARS IN ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started